NASDAQ: IMUX
Immunic Inc Stock Ownership - Who owns Immunic?

Insider buying vs selling

Have Immunic Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when IMUX insiders and whales buy or sell their stock.

IMUX Shareholders

What type of owners hold Immunic Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Muneer A. Satter52.27%7,132,277$80.10MInsider
V. Cooperatieve Ua Lsp15.85%2,162,782$24.29MInsider
Fund Nv10.05%1,371,494$15.40MInsider
Life Bioventure V. Sarl Global10.05%1,371,494$15.40MInsider
Vincent Ossipow10.05%1,371,494$15.40MInsider
Andreas Muehler4.27%582,466$6.54MInsider
Terence E. Winters3.21%438,134$4.92MInsider
Bvf Partners L P3.13%427,629$4.80MInsider
Daniel Vitt2.87%391,877$4.40MInsider
Manfred Groeppel2.04%278,830$3.13MInsider

1 of 3

IMUX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IMUX0.05%99.95%
ADCT0.06%43.59%Net Selling
CRBU0.05%8.03%Net Selling
NRXP0.02%99.98%
CRBP0.07%76.94%Net SellingNet Selling

Immunic Stock Ownership FAQ

Who owns Immunic?

Immunic (NASDAQ: IMUX) is owned by 0.06% institutional shareholders, 119.52% Immunic insiders, and 0.00% retail investors. Muneer A. Satter is the largest individual Immunic shareholder, owning 7.13M shares representing 52.27% of the company. Muneer A. Satter's Immunic shares are currently valued at $73.96M.

If you're new to stock investing, here's how to buy Immunic stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.